{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T07:41:44Z","timestamp":1698133304388},"reference-count":12,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,3,10]],"date-time":"2008-03-10T00:00:00Z","timestamp":1205107200000},"content-version":"vor","delay-in-days":5578,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[1992,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A meta\u2010analysis was performed on pooled data from five large double\u2010blind studies (a total of 1057 patients), which were conducted in Asia to compare the effects of omeprazole with H<jats:sub>2<\/jats:sub>\u2010receptor antagonists (H<jats:sub>2<\/jats:sub>\u2010RA) in duodenal ulcer. As each study followed the same protocol and data evaluation procedures, a detailed analysis of ulcer healing, symptom relief and influence of prognostic factors across the data was possible. Patients received omeprazole 20 mg om or standard doses of H<jats:sub>2<\/jats:sub>\u2010RA for a minimum of 2 and a maximum of 4 weeks, depending on healing (as verified by endoscopy). All efficacy analyses were based on per protocol data. The mean healing rates at 2 weeks were 72% for omeprazole and 42% for H<jats:sub>2<\/jats:sub>\u2010RA (difference 30%; 95% CI: 24\u201336%; <jats:italic>P<\/jats:italic>&lt; 0.0001) and at 4 weeks were 96% for omeprazole and 83% for H<jats:sub>2<\/jats:sub>\u2010RA (difference 13%; 95% CI: 10\u201317%; <jats:italic>P<\/jats:italic>&lt; 0.0001). In addition to treatment, ulcer size had a significant influence on healing, with large ulcers (diameter&gt;10 mm) taking longer to heal than small ulcers. There was no significant influence of smoking and alcohol drinking on ulcer healing. Patients on omeprazole experienced significantly less epigastric pain after 2 weeks than those on H<jats:sub>2<\/jats:sub>\u2010RA, 79% of them being completely symptom\u2010free on omeprazole compared with 65% on H<jats:sub>2<\/jats:sub>\u2010RA. The incidence of adverse events was approximately 5% on each treatment and profiles were similar for each drug. It is concluded that omeprazole, even in the presence of adverse prognostic influences, results in significantly better healing of duodenal ulcer and relief from symptoms than H<jats:sub>2<\/jats:sub>\u2010RA.<\/jats:p>","DOI":"10.1111\/j.1440-1746.1992.tb01489.x","type":"journal-article","created":{"date-parts":[[2008,3,10]],"date-time":"2008-03-10T23:00:17Z","timestamp":1205190017000},"page":"577-585","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A meta\u2010analysis comparing the efficacy of omeprazole with H<sub>2<\/sub>\u2010receptor antagonists for acute treatment of duodenal ulcer in Asian patients"],"prefix":"10.1111","volume":"7","author":[{"given":"P.","family":"BAMBERG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"CASWELL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. H.","family":"FRAME","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. K.","family":"LAM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. C. K.","family":"WONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,10]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529009093152"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01298864"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199104043241406"},{"key":"e_1_2_1_5_2","first-page":"181","article-title":"Omeprazole (Losec\u00ae) and histamine H2\u2010receptor antagonists in the treatment of peptic ulceration. A meta\u2010analysis","volume":"26","author":"Richardson P. D. I.","year":"1989","journal-title":"Clin. Trials J."},{"issue":"2","key":"e_1_2_1_6_2","first-page":"53","article-title":"Omeprazole compared with ranitidine once daily in the treatment of duodenal ulcer","volume":"5","author":"Chelvam P.","year":"1989","journal-title":"J. Gastroenterol. Hepatol."},{"key":"e_1_2_1_7_2","unstructured":"WangC. Y. WangT. H. LaiK. H.et al.A double\u2010blind comparison of omeprazole 20 mg om and ranitidine 300 mg nocte in duodenal ulcer\u2014a Taiwan multicentre study. World Congress of Gastroenterology Digestive Endoscopy and Colo\u2010proctology; Sydney 1990; Abstr. PD272. (J. Gastroenterol. Hepatol.(in press))."},{"key":"e_1_2_1_8_2","first-page":"215","article-title":"A comparison of omeprazole and ranitidine in the management of patients with duodenal ulcer","volume":"3","author":"Gloria V. I.","year":"1991","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"2","key":"e_1_2_1_9_2","first-page":"35","article-title":"Omeprazole and ranitidine in duodenal ulcer healing and subsequent relapse: A randomized double\u2010blind study with weekly endoscopic assessment","volume":"5","author":"Hui W\u2010M.","year":"1989","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"e_1_2_1_10_2","first-page":"45","article-title":"Omeprazole or cimetidine once daily for the treatment of duodenal ulcers","volume":"5","author":"Wilairatana S.","year":"1989","journal-title":"J. Gastroenterol. Hepatol."},{"key":"e_1_2_1_11_2","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel N.","year":"1959","journal-title":"J. Natl Cancer. Inst."},{"key":"e_1_2_1_12_2","first-page":"443","article-title":"Smoking as a risk factor for slow duodenal ulcer healing","volume":"3","author":"Katschinski B. D.","year":"1991","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"e_1_2_1_13_2","first-page":"527","article-title":"Famotidine, ranitidine and cimetidine in the treatment of duodenal ulcer: two large international studies","volume":"3","author":"Cochran K. M.","year":"1991","journal-title":"Eur. J. Gastroenterol. Hepatol."}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.1992.tb01489.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.1992.tb01489.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T14:39:43Z","timestamp":1698071983000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.1992.tb01489.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,12]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1992,12]]}},"alternative-id":["10.1111\/j.1440-1746.1992.tb01489.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.1992.tb01489.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,12]]},"assertion":[{"value":"2008-03-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}